Becker's Healthcare January 15, 2026
President Donald Trump released a sparsely detailed healthcare policy framework Jan. 15 that calls on Congress to codify voluntary drug pricing agreements with major pharmaceutical companies, direct payments to Americans over extending enhanced ACA subsidies, and expand price transparency requirements for insurers and providers. The proposal does not identify how most of its provisions would be implemented or enforced.
Three key takeaways:
1. Drug pricing
The “Great Healthcare Plan” would formalize the administration’s “most-favored-nation” pricing model, which ties U.S. drug costs to the lowest paid by peer nations, and preserves recent HHS and CMS agreements with drugmakers. Since September, 16 of the 17 largest drugmakers, including Pfizer, Eli Lilly and Sanofi, have signed voluntary deals applying the model to portions...
Today's Sponsors
Today's Sponsor